Roundup Cancer Lawsuit News

Roundup Lawsuits Science Day Set For February 27

A science day to help explain to a federal court the specifics of the evidence behind claims made in Monsanto Roundup cancer lawsuits will take place on February 27.

Tuesday, March 21, 2017 - A science day was held on February 27 to help educate the federal court where the multidistrict litigation related to the Monsanto Roundup lawsuits are being held. Roundup attorneys representing both plaintiffs and defendants in the case will help explain to the court the science behind the evidence they are presenting in support of their case. The plaintiffs' counsel will be explaining to the court the studies and data behind the carcinogenic nature of glyphosate, which the defense will be attempting to use their own materials to explain why they believe science supports glyphosate as a safe chemical in their weedkiller products.

Science days are often held when pharmaceutical litigation reaches an MDL court as the particulars of the research behind the claims weigh heavily on whether or not the science behind the claims is reputable. Also, the explanation of the science behind the claims can help the judge and associate judges understand the arguments being made and potentially the objection to those arguments by Roundup lawyers protesting on behalf of their clients.

Much of the science that the plaintiffs have a reference in their claims comes from medical studies into the nature of the active chemical in Roundup glyphosate and how it functions within the human body. There are studies that show how glyphosate can lead to cell dysfunction and eventually lead to an increased risk in cancer for those who have been exposed to the chemical for too long or at too close of a proximity. One of the lawsuits claims that a study published by Julie Marc in 2002 explains how "the study demonstrated a molecular link between glyphosate-based products and cell cycle dysregulation." At least three other studies were referenced which detailed the role of glyphosate in the development of cell dysfunction and the potential of creating an increased risk of cancer for people exposed to Roundup's active chemical.

Monsanto has denied these claims, and will likely be presenting rebukes to the science provided by the plaintiffs and relying on the science that resulted in glyphosate being accepted by the EPA in the first place. This will lead to another sticking point in the arguments, however, as the plaintiffs have claimed that Monsanto helped produce fraudulent data to trick the EPA by the influence the labs that were conducted research into glyphosate. These claims will likely be left for the trial and will not be covered during the science day proceedings.

The Monsanto Roundup lawsuits were consolidated into multidistrict litigation in December of 2016 after the Judicial Panel on Multidistrict Litigation determined that there were enough potential lawsuits to consolidate and that those lawsuits shared similar questions of fact regarding the claims made by Monsanto. There have been no trials scheduled to date, but there are currently battles in the California state legal system over the recent ruling that required Roundup to attach warnings to their products detailing the cancer-causing elements of glyphosate within Roundup products. Those proceedings are taking place separate from the MDL, though the arguments from those arguments could show up again as evidence in the federal proceedings.

More Recent Roundup Cancer Lawsuit News:

Lawyers for Roundup Cancer Lawsuits

Attorneys handling Roundup cancer lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Roundup cancer lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Roundup cancer lawsuit. The product liability litigators handling Roundup claims at the Onder Law Firm have a strong track record of success in representing families harmed by dangerous drugs and consumer products.